Subscribe to RSS
DOI: 10.1055/a-2806-3756
Practical Machine Learning Model for Early and Accurate Prediction of Disseminated Intravascular Coagulation Before Its Progression to an OVERT Stage
Authors
Funding Information This study was supported by a Grant from Japan Society for the Promotion of Science; Grant-in-Aid for Scientific Research C, 24K12133.

Abstract
Background
In patients with sepsis, anticoagulant therapy is expected to have maximal efficacy when administered before the development of sepsis-induced overt disseminated intravascular coagulation (DIC). This therapeutic strategy requires a valid method for real-time, early prediction of sepsis-induced DIC, which is likely to progress to an overt stage. We aimed to develop machine learning prediction models for overt DIC, based on the International Society on Thrombosis and Haemostasis criteria, using a large-scale electronic medical record database.
Methods
This multi-center, retrospective, observational study included adult patients with sepsis without overt DIC at day 1. The outcome was the development of overt DIC 24 hours after a certain time point. Predictive features were baseline data and time series data within 7 days postadmission. We constructed three separate models (minimum, compact, and full models), each incorporating increasingly comprehensive sets of features. Prediction models were constructed with machine learning algorithms, including eXtreme Gradient Boosting (XGBoost) and gradient boosting machine (GBM), and evaluated on a randomly selected 20% test set.
Results
Among 7,532 patients with sepsis, 766 developed overt DIC within 7 days. XGBoost and GBM achieved the highest prediction accuracy. The full, compact, and minimum models on the test set exhibited area under the receiver operating characteristic curve values of 0.914, 0.884, and 0.851, respectively. The full XGBoost model achieved an area under the precision–recall curve of 0.295; at 80% recall, its precision was 14.4%.
Conclusion
The machine learning model exhibited high accuracy in predicting overt DIC at a clinically reliable level.
Keywords
blood coagulation disorders - prediction - disseminated intravascular coagulation - machine learning - sepsisData Availability Statement
The data used in the analysis of this study cannot be shared due to the terms of the data provider.
Publication History
Received: 24 August 2025
Accepted after revision: 04 February 2026
Accepted Manuscript online:
10 February 2026
Article published online:
18 February 2026
© 2026. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Singer M, Deutschman CS, Seymour CW. et al. The Third International Consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315 (08) 801-810
- 2 Rudd KE, Johnson SC, Agesa KM. et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet 2020; 395 (10219): 200-211
- 3 Gando S, Shiraishi A, Yamakawa K. et al; Japanese Association for Acute Medicine (JAAM) Focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome, Sepsis and Trauma (FORECAST) Study Group. Role of disseminated intravascular coagulation in severe sepsis. Thromb Res 2019; 178: 182-188
- 4 Iba T, Levy JH, Maier CL. et al. Updated definition and scoring of disseminated intravascular coagulation in 2025: communication from the ISTH SSC subcommittee on disseminated intravascular coagulation. J Thromb Haemost 2025; 23 (07) 2356-2362
- 5 Rhodes A, Evans LE, Alhazzani W. et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017; 43 (03) 304-377
- 6 Evans L, Rhodes A, Alhazzani W. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 2021; 47 (11) 1181-1247
- 7 Umemura Y, Yamakawa K, Ogura H, Yuhara H, Fujimi S. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials. J Thromb Haemost 2016; 14 (03) 518-530
- 8 Yamakawa K, Umemura Y, Hayakawa M. et al; Japan Septic Disseminated Intravascular Coagulation (J-Septic DIC) study group. Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan. Crit Care 2016; 20 (01) 229
- 9 Iba T, Helms J, Connors JM, Levy JH. The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation. J Intensive Care 2023; 11 (01) 24
- 10 Collins GS, Moons KGM. Reporting of artificial intelligence prediction models. Lancet 2019; 393 (10181): 1577-1579
- 11 Forrest IS, Petrazzini BO, Duffy Á. et al. Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts. Lancet 2023; 401 (10372): 215-225
- 12 Siontis KC, Noseworthy PA, Attia ZI, Friedman PA. Artificial intelligence-enhanced electrocardiography in cardiovascular disease management. Nat Rev Cardiol 2021; 18 (07) 465-478
- 13 Yu YD, Lee KS, Man Kim J. et al; Korean Organ Transplantation Registry Study Group. Artificial intelligence for predicting survival following deceased donor liver transplantation: retrospective multi-center study. Int J Surg 2022; 105: 106838
- 14 Patel UK, Anwar A, Saleem S. et al. Artificial intelligence as an emerging technology in the current care of neurological disorders. J Neurol 2021; 268 (05) 1623-1642
- 15 Umemura Y, Okada N, Ogura H, Oda J, Fujimi S. A machine learning model for early and accurate prediction of overt disseminated intravascular coagulation before its progression to an overt stage. Res Pract Thromb Haemost 2024; 8 (05) 102519
- 16 Taylor Jr FB, Toh CH, Hoots WK, Wada H, Levi M. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86 (05) 1327-1330
- 17 Gando S, Saitoh D, Ogura H. et al; Japanese Association for Acute Medicine Sepsis Registry Study Group. A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis. Crit Care 2013; 17 (03) R111
- 18 Lundberg SM, Lee S-I. A unified approach to interpreting model predictions. Adv Neural Inf Process Syst 2017; 30: 4765-4774
- 19 Iba T, Arakawa M, Di Nisio M. et al. Newly proposed sepsis-induced coagulopathy precedes International Society on Thrombosis and Haemostasis overt-disseminated intravascular coagulation and predicts high mortality. J Intensive Care Med 2020; 35 (07) 643-649
- 20 Wada H, Sase T, Matsumoto T. et al. Increased soluble fibrin in plasma of patients with disseminated intravascular coagulation. Clin Appl Thromb Hemost 2003; 9 (03) 233-240
- 21 Jackson Chornenki NL, Dwivedi DJ, Kwong AC, Zamir N, Fox-Robichaud AE, Liaw PC. Canadian Critical Care Translational Biology Group. Identification of hemostatic markers that define the pre-DIC state: a multi-center observational study. J Thromb Haemost 2020; 18 (10) 2524-2531
- 22 Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348 (16) 1546-1554
- 23 Pine M, Jordan HS, Elixhauser A. et al. Enhancement of claims data to improve risk adjustment of hospital mortality. JAMA 2007; 297 (01) 71-76